An Opportunity Missed: Biosimilars in the United States

被引：5

作者：

Goll, Guro L. ^{[1
]}

Kvien, Tore K. ^{[1
]}

机构：

[1] Diakonhjemmet Hosp, Oslo, Norway

来源：

关键词：

DOUBLE-BLIND; ORIGINATOR INFLIXIMAB; INNOVATOR INFLIXIMAB; PARALLEL-GROUP; CT-P13; ARTHRITIS; EFFICACY; SAFETY; SWITCH;

D O I：

10.1002/art.41280

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1046 / 1048

页数：3

共 50 条

[41] Missed opportunity
Heintzel, Alexander
ATZ worldwide, 2013, 115 (05)
[42] Missed opportunity
Wagner, B
INTERNATIONALE POLITIK, 2005, 60 (10): : 76 - 83
[43] AN OPPORTUNITY NOT TO BE MISSED
BELLI, AM
ELLIOTT, C
HERON, CW
BRITISH JOURNAL OF RADIOLOGY, 1988, 61 (722): : 171 - 172
[44] Missed opportunity
Dukes, J
PHOTONICS SPECTRA, 2000, 34 (03) : 15 - 15
[45] OPPORTUNITY MISSED
不详
MACHINERY AND PRODUCTION ENGINEERING, 1974, 124 (3202): : 413 - 413
[46] A Missed Opportunity
Van Wert, Ryan
McKenna, Ann Marie
Smith, Christopher A.
Vadas, Peter
Detsky, Allan S.
Mourad, Ophyr
JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (05) : 728 - 732
[47] A missed opportunity
Tessier, D
CANADIAN FAMILY PHYSICIAN, 1997, 43 : 2107 - 2107
[48] A missed opportunity
不详
EDUCATIONAL LEADERSHIP, 2007, 64 (05) : 92 - 93
[49] Missed opportunity
Gauk, Ehor William
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 179 (02) : 164 - 164
[50] Missed opportunity
Singer, R
CHEMICAL ENGINEER-LONDON, 1998, (667): : 34 - 34